The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns.
Gurwitz
David
D
Weizman
Abraham
A
D000818:Animals; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D051379:Mice; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000235:genetics*
D006213:Hallucinogens; C121001:NR2B NMDA receptor; D016194:Receptors, N-Methyl-D-Aspartate